Eric Pamer

Eric Pamer

University of Chicago

H-index: 122

North America-United States

Professor Information

University

University of Chicago

Position

Duchossois Family Institute

Citations(all)

62905

Citations(since 2020)

27495

Cited By

47079

hIndex(all)

122

hIndex(since 2020)

80

i10Index(all)

243

i10Index(since 2020)

174

Email

University Profile Page

University of Chicago

Research & Interests List

Microbiota

Human Microbiome

Immunology

Infectious Diseases

Top articles of Eric Pamer

Activity of Gut-Derived Nisin-like Lantibiotics against Human Gut Pathogens and Commensals

Recent advances in sequencing techniques unveiled the vast potential of ribosomally synthesized and post-translationally modified peptides (RiPPs) encoded in microbiomes. Class I lantibiotics such as nisin A, widely used as a food preservative, have been investigated for their efficacy in killing pathogens. However, the impact of nisin and nisin-like class I lantibiotics on commensal bacteria residing in the human gut remains unclear. Here, we report six gut-derived class I lantibiotics that are close homologues of nisin, four of which are novel. We applied an improved lantibiotic expression platform to produce and purify these lantibiotics for antimicrobial assays. We determined their minimal inhibitory concentration (MIC) against both Gram-positive human pathogens and gut commensals and profiled the lantibiotic resistance genes in these pathogens and commensals. Structure–activity relationship (SAR) studies …

Authors

Zhenrun J Zhang,Chunyu Wu,Ryan Moreira,Darian Dorantes,Téa Pappas,Anitha Sundararajan,Huaiying Lin,Eric G Pamer,Wilfred A van der Donk

Journal

ACS Chemical Biology

Published Date

2024/1/31

Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection

Metabolites produced by the intestinal microbiome modulate mucosal immune defenses and optimize epithelial barrier function. Intestinal dysbiosis, including loss of intestinal microbiome diversity and expansion of antibiotic-resistant pathobionts, is accompanied by changes in fecal metabolite concentrations and increased incidence of systemic infection. Laboratory tests that quantify intestinal dysbiosis, however, have yet to be incorporated into clinical practice. We quantified fecal metabolites in 107 patients undergoing liver transplantation (LT) and correlated these with fecal microbiome compositions, pathobiont expansion, and postoperative infections. Consistent with experimental studies implicating microbiome-derived metabolites with host-mediated antimicrobial defenses, reduced fecal concentrations of short- and branched-chain fatty acids, secondary bile acids, and tryptophan metabolites correlate with …

Authors

Christopher J Lehmann,Nicholas P Dylla,Matthew Odenwald,Ravi Nayak,Maryam Khalid,Jaye Boissiere,Jackelyn Cantoral,Emerald Adler,Matthew R Stutz,Mark Dela Cruz,Angelica Moran,Huaiying Lin,Ramanujam Ramaswamy,Anitha Sundararajan,Ashley M Sidebottom,Jessica Little,Eric G Pamer,Andrew Aronsohn,John Fung,Talia B Baker,Aalok Kacha

Journal

Cell host & microbe

Published Date

2024/1/10

Dietary-and host-derived metabolites are used by diverse gut bacteria for anaerobic respiration

Respiratory reductases enable microorganisms to use molecules present in anaerobic ecosystems as energy-generating respiratory electron acceptors. Here we identify three taxonomically distinct families of human gut bacteria (Burkholderiaceae, Eggerthellaceae and Erysipelotrichaceae) that encode large arsenals of tens to hundreds of respiratory-like reductases per genome. Screening species from each family (Sutterella wadsworthensis, Eggerthella lenta and Holdemania filiformis), we discover 22 metabolites used as respiratory electron acceptors in a species-specific manner. Identified reactions transform multiple classes of dietary- and host-derived metabolites, including bioactive molecules resveratrol and itaconate. Products of identified respiratory metabolisms highlight poorly characterized compounds, such as the itaconate-derived 2-methylsuccinate. Reductase substrate profiling defines enzyme …

Authors

Alexander S Little,Isaac T Younker,Matthew S Schechter,Paola Nol Bernardino,Raphaël Méheust,Joshua Stemczynski,Kaylie Scorza,Michael W Mullowney,Deepti Sharan,Emily Waligurski,Rita Smith,Ramanujam Ramanswamy,William Leiter,David Moran,Mary McMillin,Matthew A Odenwald,Anthony T Iavarone,Ashley M Sidebottom,Anitha Sundararajan,Eric G Pamer,A Murat Eren,Samuel H Light

Journal

Nature Microbiology

Published Date

2024/1/4

Methods and compositions for identifying and treating subjects at risk for poor CAR T cell therapy response

The present disclosure relates to compositions and methods for the diagnosis and treatment or prevention of cancers that exhibit elevated expression of the glutamate/cysteine transporter SLC7A11, reduced expression of the fatty acid transporter SLC25A45 and/or reduced expression of FAM3 metabolism regulating signaling molecule B (FAM3B). In particular, the instant disclosure provides for identification of a cancer as possessing elevated SLC7A11 expression, reduced expression of SLC25A45 and/or reduced expression of FAM3B, and selecting and/or administering a glutaminase inhibitor as a therapeutic agent for such a cancer and/or subject having or at risk of developing such a cancer. Methods and compositions for therapies that combine such selection of cancers/subjects for glutaminase inhibitor therapy with other cancer therapies and/or chemotherapeutic agents are also provided.

Published Date

2023/5/18

Intestinal carbapenem-resistant Klebsiella pneumoniae undergoes complex transcriptional reprogramming following immune activation

Carbapenem-resistant Klebsiella pneumoniae (CR-Kp) is a significant threat to public health worldwide. The primary reservoir for CR-Kp is the intestinal tract. There, the bacterium is usually present at low density but can bloom following antibiotic treatment, mostly in hospital settings. The impact of disturbances in the intestinal environment on the fitness, survival, expansion, and drug susceptibility of this pathogen is not well-understood, yet it may be relevant to devise strategies to tackle CR-Kp colonization and infection. Here, we adopted an in vivo model to examine the transcriptional adaptation of a CR-Kp clinical isolate to immune activation in the intestine. We report that as early as 6 hours following host treatment with anti-CD3 antibody, CR-Kp underwent rapid transcriptional changes including downregulation of genes involved in sugar utilization and amino acid biosynthesis and upregulation of genes …

Authors

Clement David,Aleksander Czauderna,Liqing Cheng,Marion Lagune,Hea-Jin Jung,Sohn G Kim,Eric G Pamer,Julien Prados,Liang Chen,Simone Becattini

Journal

Gut Microbes

Published Date

2024/12/31

Comprehensive analyses of a large human gut Bacteroidales culture collection reveal species and strain level diversity and evolution

Species of the Bacteroidales order are among the most abundant and stable bacterial members of the human gut microbiome with diverse impacts on human health. While Bacteroidales strains and species are genomically and functionally diverse, order-wide comparative analyses are lacking. We cultured and sequenced the genomes of 408 Bacteroidales isolates from healthy human donors representing nine genera and 35 species and performed comparative genomic, gene-specific, mobile gene, and metabolomic analyses. Families, genera, and species could be grouped based on many distinctive features. However, we also show extensive DNA transfer between diverse families, allowing for shared traits and strain evolution. Inter- and intra-specific diversity is also apparent in the metabolomic profiling studies. This highly characterized and diverse Bacteroidales culture collection with strain-resolved genomic and metabolomic analyses can serve as a resource to facilitate informed selection of strains for microbiome reconstitution.

Authors

Zhenrun J Zhang,Cody G Cole,Michael Coyne,Huaiying Lin,Nicholas Dylla,Rita C Smith,Emily Waligurski,Ramanujam Ramaswamy,Che Woodson,Victoria Burgo,Jessica Little,David Moran,Amber Rose,Mary McMillin,Emma McSpadden,Anitha Sundararajan,Ashley Sidebottom,Eric G Pamer,Laurie E Comstock

Journal

bioRxiv

Published Date

2024

Biomarkers of risk for infection

BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha, 5alpha, 7alpha, 12alpha)-3, 7, 12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC (O) CCC2 (C) C2C1C1CCC (C (CCC (O)= O) C) C1 (C) C (O) C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 claims description 16

Published Date

2024/2/29

Virulence and genomic diversity among clinical isolates of ST1 (BI/NAP1/027) Clostridioides difficile

Clostridioides difficile produces toxins that damage the colonic epithelium, causing colitis. Variation in disease severity is poorly understood and has been attributed to host factors and virulence differences between C. difficile strains. We test 23 epidemic ST1 C. difficile clinical isolates for their virulence in mice. All isolates encode a complete Tcd pathogenicity locus and achieve similar colonization densities. However, disease severity varies from lethal to avirulent infections. Genomic analysis of avirulent isolates reveals a 69-bp deletion in the cdtR gene, which encodes a response regulator for binary toxin expression. Deleting the 69-bp sequence in virulent R20291 strain renders it avirulent in mice with reduced toxin gene transcription. Our study demonstrates that a natural deletion within cdtR attenuates virulence in the epidemic ST1 C. difficile isolates without reducing colonization and persistence. Distinguishing …

Authors

Qiwen Dong,Huaiying Lin,Marie-Maude Allen,Julian R Garneau,Jonathan K Sia,Rita C Smith,Fidel Haro,Tracy McMillen,Rosemary L Pope,Carolyn Metcalfe,Victoria Burgo,Che Woodson,Nicholas Dylla,Claire Kohout,Anitha Sundararajan,Evan S Snitkin,Vincent B Young,Louis-Charles Fortier,Mini Kamboj,Eric G Pamer

Journal

Cell reports

Published Date

2023/8/29

Professor FAQs

What is Eric Pamer's h-index at University of Chicago?

The h-index of Eric Pamer has been 80 since 2020 and 122 in total.

What are Eric Pamer's research interests?

The research interests of Eric Pamer are: Microbiota, Human Microbiome, Immunology, Infectious Diseases

What is Eric Pamer's total number of citations?

Eric Pamer has 62,905 citations in total.

What are the co-authors of Eric Pamer?

The co-authors of Eric Pamer are Eric Littmann, Simone Becattini.

Co-Authors

H-index: 26
Eric Littmann

Eric Littmann

University of Chicago

H-index: 15
Simone Becattini

Simone Becattini

Université de Genève

academic-engine

Useful Links